DK1140915T3 - 4-(aminomethyl)-piperidinbenzamider til behandling af gastrointestinale forstyrrelser - Google Patents

4-(aminomethyl)-piperidinbenzamider til behandling af gastrointestinale forstyrrelser

Info

Publication number
DK1140915T3
DK1140915T3 DK99967956T DK99967956T DK1140915T3 DK 1140915 T3 DK1140915 T3 DK 1140915T3 DK 99967956 T DK99967956 T DK 99967956T DK 99967956 T DK99967956 T DK 99967956T DK 1140915 T3 DK1140915 T3 DK 1140915T3
Authority
DK
Denmark
Prior art keywords
aminomethyl
treatment
gastrointestinal disorders
piperidine benzamides
benzamides
Prior art date
Application number
DK99967956T
Other languages
Danish (da)
English (en)
Inventor
Jean-Paul Rene Marie A Bosmans
Cleyn Michel Anna Jozef De
Henricus Jacobus Maria Gijsen
Ann Louise Gabrielle Meulemans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1140915T3 publication Critical patent/DK1140915T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99967956T 1998-12-22 1999-12-14 4-(aminomethyl)-piperidinbenzamider til behandling af gastrointestinale forstyrrelser DK1140915T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204411 1998-12-22
PCT/EP1999/010064 WO2000037461A1 (en) 1998-12-22 1999-12-14 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders

Publications (1)

Publication Number Publication Date
DK1140915T3 true DK1140915T3 (da) 2005-10-10

Family

ID=8234539

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99967956T DK1140915T3 (da) 1998-12-22 1999-12-14 4-(aminomethyl)-piperidinbenzamider til behandling af gastrointestinale forstyrrelser

Country Status (34)

Country Link
US (2) US6544997B1 (tr)
EP (1) EP1140915B1 (tr)
JP (1) JP4615725B2 (tr)
KR (1) KR100633680B1 (tr)
CN (1) CN1150190C (tr)
AR (1) AR024240A1 (tr)
AT (1) ATE297917T1 (tr)
AU (1) AU770397B2 (tr)
BG (1) BG64953B1 (tr)
BR (1) BR9916491A (tr)
CA (1) CA2355857C (tr)
CZ (1) CZ300851B6 (tr)
DE (1) DE69925865T2 (tr)
DK (1) DK1140915T3 (tr)
EA (1) EA003608B1 (tr)
EE (1) EE200100335A (tr)
ES (1) ES2245131T3 (tr)
HK (1) HK1039114B (tr)
HR (1) HRP20010445A2 (tr)
HU (1) HUP0104838A3 (tr)
ID (1) ID28953A (tr)
IL (1) IL143858A (tr)
MY (1) MY121852A (tr)
NO (1) NO321324B1 (tr)
NZ (1) NZ512871A (tr)
PL (1) PL197409B1 (tr)
PT (1) PT1140915E (tr)
SI (1) SI1140915T1 (tr)
SK (1) SK285829B6 (tr)
TR (1) TR200101962T2 (tr)
TW (1) TW570920B (tr)
UA (1) UA71591C2 (tr)
WO (1) WO2000037461A1 (tr)
ZA (1) ZA200105135B (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370983C (zh) * 2002-09-12 2008-02-27 长濑化成株式会社 药物组合物
EP1638961B1 (en) * 2003-06-19 2009-11-18 Janssen Pharmaceutica N.V. Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
CA2526079C (en) * 2003-06-19 2012-01-10 Janssen Pharmaceutica N.V. Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
AU2004254193B2 (en) * 2003-06-19 2010-02-18 Janssen Pharmaceutica N.V. 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides
ES2355824T3 (es) * 2003-06-19 2011-03-31 Janssen Pharmaceutica Nv 4-(aminometil)-piperidina-benzamidas sustituidas con hidroxicarbonilfenilo como antagonistas 5ht4.
JO2478B1 (en) * 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
OA13248A (en) * 2003-09-03 2007-01-31 Pfizer Benzimidazolone coumpounds having 5-HT4 receptor agonistic activity.
ES2338882T3 (es) * 2003-11-24 2010-05-13 Pfizer, Inc. Compuestos de acido quinolona-carboxilico que tienen actividad agonista del receptor 5-ht4.
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
GEP20094638B (en) 2004-06-15 2009-03-10 Pfizer Benzimidazolone carboxylic acid derivatives
US20060035890A1 (en) * 2004-08-10 2006-02-16 Amit Banerjee Compounds and methods for the treatment of ubiquitin conjugating disorders
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
DE602005014566D1 (de) * 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
CA2588037A1 (en) * 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
NZ560828A (en) * 2005-03-02 2011-01-28 Theravance Inc Quinolinone compounds as 5-HT4 receptor agonists
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8377968B2 (en) 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
US10208023B2 (en) 2013-03-01 2019-02-19 Mark G. DeGiacomo Heterocyclic inhibitors of the sodium channel
US20180305334A1 (en) * 2015-10-14 2018-10-25 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
BR112022000429A2 (pt) 2019-07-11 2022-03-29 Praxis Prec Medicines Inc Formulações de moduladores do canal de cálcio tipo t e métodos de uso dos mesmos

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
AU2435092A (en) 1991-08-20 1993-03-16 Smithkline Beecham Plc 5-ht4 receptor antagonists
CZ283619B6 (cs) * 1991-09-12 1998-05-13 Smithkline Beecham P.L.C Použití derivátů kyseliny benzoové pro výrobu farmaceutických prostředků, deriváty kyseliny benzoo vé, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
WO1993015081A1 (fr) * 1992-01-23 1993-08-05 Toray Industries, Inc. Derive de morphinane et utilisation en medicine
WO1993016072A1 (en) * 1992-02-06 1993-08-19 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
GB9219163D0 (en) 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AU5150393A (en) 1992-10-13 1994-05-09 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
AU680453B2 (en) * 1992-11-05 1997-07-31 Smithkline Beecham Plc Piperidine derivatives as 5-HT4 receptor antagonists
GB9301660D0 (en) 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9507882D0 (en) 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
KR100469029B1 (ko) * 1996-02-15 2005-05-27 얀센 파마슈티카 엔.브이. 세로토닌재흡수억제제의위장효과를극복하기위한5ht4수용체길항제의용도
TW445263B (en) 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
CA2340952C (en) * 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
DE10217868A1 (de) * 2002-04-22 2003-10-30 Jomed N V Ballon-Katheter

Also Published As

Publication number Publication date
ES2245131T3 (es) 2005-12-16
TW570920B (en) 2004-01-11
HK1039114B (zh) 2005-08-19
EA200100710A1 (ru) 2001-12-24
ATE297917T1 (de) 2005-07-15
JP2002533337A (ja) 2002-10-08
KR20010080293A (ko) 2001-08-22
AU2432800A (en) 2000-07-12
DE69925865T2 (de) 2006-05-11
ID28953A (id) 2001-07-19
NO20012858L (no) 2001-06-08
TR200101962T2 (tr) 2002-04-22
EA003608B1 (ru) 2003-06-26
PL197409B1 (pl) 2008-03-31
CA2355857C (en) 2008-10-28
AU770397B2 (en) 2004-02-19
KR100633680B1 (ko) 2006-10-11
CZ20012117A3 (cs) 2001-10-17
DE69925865D1 (de) 2005-07-21
SI1140915T1 (sl) 2005-12-31
IL143858A0 (en) 2002-04-21
CN1150190C (zh) 2004-05-19
HRP20010445A2 (en) 2002-06-30
ZA200105135B (en) 2002-06-21
EP1140915B1 (en) 2005-06-15
HK1039114A1 (en) 2002-04-12
BR9916491A (pt) 2001-09-04
IL143858A (en) 2005-03-20
SK285829B6 (sk) 2007-09-06
CA2355857A1 (en) 2000-06-29
NZ512871A (en) 2002-11-26
JP4615725B2 (ja) 2011-01-19
SK8592001A3 (en) 2002-02-05
MY121852A (en) 2006-02-28
AR024240A1 (es) 2002-09-25
EP1140915A1 (en) 2001-10-10
PL348417A1 (en) 2002-05-20
PT1140915E (pt) 2005-11-30
UA71591C2 (en) 2004-12-15
CN1331690A (zh) 2002-01-16
HUP0104838A2 (hu) 2002-07-29
EE200100335A (et) 2002-08-15
BG64953B1 (bg) 2006-10-31
CZ300851B6 (cs) 2009-08-26
US20030181456A1 (en) 2003-09-25
WO2000037461A1 (en) 2000-06-29
HUP0104838A3 (en) 2003-05-28
US6544997B1 (en) 2003-04-08
NO321324B1 (no) 2006-04-24
US7205410B2 (en) 2007-04-17
NO20012858D0 (no) 2001-06-08
BG105571A (en) 2002-01-31

Similar Documents

Publication Publication Date Title
DK1140915T3 (da) 4-(aminomethyl)-piperidinbenzamider til behandling af gastrointestinale forstyrrelser
ID24161A (id) Gastrokinetik benzamida bisiklik dari derivat-derivat 3-atau 4-tersubstitusi 4-(aminometil) - piperidin
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
DK1443955T3 (da) PDGF-BB til behandling af Parkinsons sygdom
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1362857T3 (da) (S)-4-amino-5-chlor-2-methoxy-N-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamid til behandling af gastrointestinale motilitetslidelser
DK0967214T3 (da) Intranasale formuleringer til behandling af seksuelle forstyrrelser
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
NO20033417D0 (no) Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DE60236863D1 (de) Elektrisch beheizte einbaubohle
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
DK0854146T3 (da) Substitueret 4-(6-fluor-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridin til behandling af CNS forstyrrelser
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner